Sildenafil Tablet
Product Images NDC 70518-4596

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 70518-4596). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

This is a description of a Sildenafil tablet with a potency of 20 mg. It is presented as one tablet with NDC code 70518-4596-01. The tablet is round, white, and imprinted with 'AN;351'. The medication is repackaged by a company named RemedyRepack Inc. in Indiana, PA. The manufacturing NDC is 65162-0351-11 belonging to Amneal Pharma, located in Bridgewater, NJ. The standard dosage instructions are provided in the insert. The medication should be stored at 20-25°C (68-77°F) with excursions allowed to 15-30°C (59-86°F) as per USP guidelines.*

FDA Label Image

Mm1 (Sildenafil 20mg 70518 4596 00)

This is a description of a box of Sildenafil tablets containing 250 tablets with a strength of 20 mg each. The tablets are white and round in shape. The manufacturer is Amneal Pharma located in Bridgewater, NJ. The medication is repackaged by RemedyRepack, located in Indiana, PA. The usual dosage instructions are provided in the insert included in the packaging. It is advised to keep the medication away from children and store it at a temperature between 20-25°C (68-77°F), with excursions permitted between 15-30°C (59-86°F) as per USP guidelines.*

FDA Label Image

4 (Sildenafil Tablets 20mg 1)

FDA Label Image

1 (Sildenafil Tablets 20mg 2)

This text provides information on the recommended drug interactions with various medications like Atorvastatin, Ritonavir, and Saquinavir. It specifies whether dose adjustment is needed for drugs like Bosentan, Cimetidine, Erythromycin, and Maalox. The text also includes a note on oral contraceptives and their use. The document further mentions the change in values concerning Sildenafil alone and specifies that there is no benefit on exercise capacity when sildenafil is added to bosentan therapy.*

FDA Label Image

1 (Sildenafil Tablets 20mg 3)

This list provides recommendations on drug dosing adjustments based on interactions with other medications for various drugs such as Acenocoumarol, Aspirin, Atorvastatin, Bosentan, Doxazosin, Ethinyloestradiol, Levonorgestrel, Phenprocoumon, Ritonavir, Saquinavir, and Tolbutamide. Dose adjustments, coadministration and recommendations are provided for each drug based on AUC (area under the curve) and Cmax (maximum plasma concentration). The information also includes references to bleeding time, exercise capacity, and the impact of ritonavir on sildenafil PK.*

FDA Label Image

F7c6df1a-figure-05 (Sildenafil Tablets 20mg 4)

FDA Label Image

10.1 (Sildenafil Tablets 20mg 5)

FDA Label Image

F7c6df1a-figure-07 (Sildenafil Tablets 20mg 6)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.